Avanos Medical AVNS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Reportable segment operating income (loss) by Business | ||||||
| PM&R | $7.2M+44.0% | $9.2M+241% | $7.9M+472% | $6.7M+274% | $5M+203% | |
| Total Specialty Nutrition Systems | $84.6M-2.2% | $82.6M+2.2% | $87.1M+14.9% | $82.7M+7.1% | $86.5M+14.7% | |
| Other segment items by Business | ||||||
| PM&R | -$100K— | -$100K— | —— | —— | —— | |
| General expenses by Business | ||||||
| PM&R | -$48.1M-20.0% | -$48.5M-27.6% | -$46M-17.0% | -$43.9M-11.1% | -$40.1M-1.0% | |
| Total Specialty Nutrition Systems | -$72.8M-28.2% | -$69.5M-27.3% | -$65.4M-18.1% | -$61.5M-12.5% | -$56.8M-5.3% | |
| Currency translation adjustment by Business | ||||||
| PM&R | $2M— | $2.6M— | —— | —— | —— | |
| Total Specialty Nutrition Systems | $0— | $0— | —— | —— | —— | |
| Advertising, promotion and selling expenses by Business | ||||||
| PM&R | -$63.3M+13.5% | -$62.3M+20.1% | -$66.1M+14.0% | -$68.6M+11.7% | -$73.2M+3.8% | |
| Total Specialty Nutrition Systems | -$56.9M+7.9% | -$53.6M+20.0% | -$56M+12.3% | -$58.4M+7.5% | -$61.8M+0.4% | |
| Cost of goods sold by Business | ||||||
| PM&R | -$86.7M-2.4% | -$85.7M-1.7% | -$86M-2.7% | -$85.9M-4.2% | -$84.7M-3.5% | |
| Total Specialty Nutrition Systems | -$177.9M-27.4% | -$165.1M-21.8% | -$154.5M-18.2% | -$146.3M-16.1% | -$139.6M-11.5% | |
| Depreciation and amortization expense by Business | ||||||
| PM&R | -$14.5M-4.3% | -$14.7M-9.7% | -$14.4M-7.3% | -$14.2M-6.4% | -$13.9M-3.9% | |
| Total Specialty Nutrition Systems | -$21.5M-25.0% | -$20.4M-24.4% | -$18.3M-6.7% | -$17.6M-1.7% | -$17.2M+2.0% | |
| Distribution by Business | ||||||
| PM&R | -$13.1M-21.3% | -$12.6M-20.0% | -$11.9M-13.6% | -$11.1M+0.4% | -$10.8M+4.6% | |
| Total Specialty Nutrition Systems | -$25.7M-8.4% | -$24.9M-0.8% | -$24.9M-4.0% | -$24M+1.2% | -$23.7M+1.0% | |
| Research and development expenses by Business | ||||||
| PM&R | -$5M+21.9% | -$4.8M+34.2% | -$4.7M+45.0% | -$5.4M+40.0% | -$6.4M+31.6% | |
| Total Specialty Nutrition Systems | -$16.3M+5.2% | -$16.7M+3.5% | -$17.2M-3.9% | -$17.5M-12.9% | -$17.2M-13.5% | |
| Goodwill by Business | ||||||
| PM&R | $212.7M— | $288.3M— | $362.7M— | —— | —— | |
| Total Specialty Nutrition Systems | $1.35B— | $1.34B— | $1.32B— | —— | —— | |
| Net Sales by Product | ||||||
| Enteral feeding | $324.8M+10.4% | $314.7M+8.6% | $306.7M+7.4% | $296M+4.1% | $294.2M+4.2% | |
| Neonate solutions | $131M+20.5% | $118.2M+10.8% | $117M+19.5% | $111.9M+19.4% | $108.7M+19.7% | |
| Radiofrequency ablation | $141.8M+10.3% | $139M+10.1% | $136.2M+13.9% | $132.9M+14.9% | $128.6M+15.2% | |
| Surgical pain and recovery | $96.1M-8.9% | $98.8M-8.5% | $100.8M+5.9% | $102.9M+0.1% | $105.5M-3.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Avanos Medical break its business down?
- Avanos Medical (AVNS) reports reportable segment operating income (loss) by business across 2 parts — PM&R and Total Specialty Nutrition Systems. Each is extracted from the segment footnotes and tracked over time.
- Where does Avanos Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Avanos Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
